Fragilis (AA 21-133) 抗体
-
- 抗原
- Fragilis
-
抗原表位
- AA 21-133
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- 非结合性
-
应用范围
- Western Blotting (WB)
- 预测反应
- Human
- 免疫原
- KLH conjugated synthetic peptide derived from human Fragilis
- 克隆位点
- S12F3
-
-
- 应用备注
- WB 1:300-5000
- 限制
- 仅限研究用
-
- 浓度
- 0.5 μg/μL
- 缓冲液
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- 4 °C,-20 °C
- 储存方法
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- 有效期
- 12 months
-
- 抗原
- Fragilis
- 背景
-
Synonyms: 1 8U, Ifitm 3, IFITM3, IFM3_HUMAN, Interferon induced transmembrane protein 3 (1 8U), Interferon Induced Transmembrane Protein 3, Interferon inducible, Interferon inducible protein 1 8U, Interferon Inducible Protein 15, Interferon Inducible Protein Homolog, Interferon-induced transmembrane protein 3, Interferon-inducible protein 1-8U, IP15.
Background: IFN-induced antiviral protein that mediates cellular innate immunity to at least three major human pathogens, namely influenza A H1N1 virus, West Nile virus (WNV), and dengue virus (WNV), by inhibiting the early step(s) of replication.
- 基因ID
- 10410
- UniProt
- Q01628
-